The global bio decontamination market size was valued at USD 159 million in 2021, is estimated to reach USD 227 million by 2030 and expanding at a CAGR of 7.3% during the forecast period, 2021–2030. The growth of the market is attributed to the increasing incidence HAIs and rising number of surgical procedures.
Bio decontamination is the process of neutralizing or removing chemical agents, radioactive components, and pathogenic bacteria. Bio decontamination is done by using chemical agents, or by biological methods. Thermal and high-pressure techniques are just two examples of physical bio decontamination treatments. Surfactants are used in chemical decontamination processes to neutralize oxidizing agents, chemical waste, and other substances. An enzymatic systems, artificial bacteria, and other decontamination techniques are included in the bio decontamination process.
Revenue for businesses in the bio decontamination sector in 2020 has also been influenced by COVID-19 pandemic. For instance, due to the high demand for bio decontamination solutions, Bioquell Global Healthcare & Life Sciences saw a 22 percent growth in sales in 2020. However, segmental sales fell by 4% in 2021 as a result of the COVID-19's milder symptoms. Additionally, hospitals employed bio decontamination services in 2021 to transform COVID-19 units into regular wards. For instance, the emergency COVID-19 ward was able to resume normal operations thanks to Bioquell's rapid bio decontamination service (RBDS).
Market Trends, Drivers, Restraints, and Opportunities
- Rising advancements in biotechnology and pharmaceutical industry is expected to drive the market.
- Increasing prevalence of hospital acquired infections and heightened efficiency in healthcare institutions is projected to propel the market during the forecast period.
- Presence of manual bio decontamination methods and budgetary constraints in healthcare facilities is anticipated to hinder the market.
- Lack of awareness about the bio decontamination is expected to hamper the market in the coming years.
- Government guidelines for clean and sterile environments and outsourcing of bio decontamination product is projected to create lucrative opportunities for market players.
Scope of the Report
The report on the global bio decontamination market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Bio Decontamination Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2021 |
| Historic Data | 2019–2020 |
| Forecast Period | 2022–2030 |
| Segmentation | Chemical Agents (Nitrogen, Peracetic Acid, and Hydrogen Peroxide), Products (Services, Equipment, and Consumables), Types (Chamber Decontamination and Room Decontamination), and End-users (Hospitals & Healthcare Facilities, Clinics, Biotechnology Research Organizations, and Others) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | JCE Biotechnology; Fedegari Autoclavi SpA; Steris PLC; Ecolab; and TOMI Environmental Solutions, Inc |
Market Segment Insights
Peracetic acid segment to expand at a considerable CAGR
On the basis of chemical agents, the bio decontamination market is segmented into nitrogen, peracetic acid, and hydrogen peroxide. The peracetic acid segment is projected to expand at a considerable CAGR during the forecast period, as peracetic acid-based disinfectant is the most appropriate solution for a biological decontamination procedure. The hydrogen peroxide segment is anticipated to account for a major market share during the forecast period. H2O2 is a potent oxidant with a high level of antibacterial activity against a wide variety of bacteria or bacterial spores, therefore it is widely used as a bio decontamination agent.
Equipment segment to hold a significant share of the market
Based on products, the market is divided into services, equipment, and consumables. The equipment segment is expected to hold a significant share of the market in the coming years, due to increasing equipment demand in bio-pharma companies to maintain aseptic conditions. A large number of end-users are choosing automated equipment over manually operated equipment and manual methods for the decontamination of the site, due to their greater accuracy and efficiency. The services segment accounts for a significant market share, owing to the launch of advanced instruments, portability, and minimal footprints and the need for less manual intervention.
Room decontamination segment to expand at a substantial CAGR
On the basis of types, the bio decontamination market is segregated into chamber decontamination and room decontamination. The room decontamination segment is anticipated to expand at a substantial CAGR during the forecast period. The greater pace of bio decontamination in cleanrooms has been made possible by the pressing demand for an optimum degree of cleanliness and microbiological control. The chamber decontamination segment is expected to hold a significant share of the market, due to the rising demand for portable solutions and advanced instruments.
Hospitals & healthcare facilities segment to register considerable market share
Based on end-users, the market is segmented into hospitals & healthcare facilities, clinics, biotechnology research organizations, and others. The hospitals & healthcare facilities segment is projected to register considerable share of the market in the coming years, owing to rising government support towards healthcare infrastructure. The biotechnology research organizations segment is expected to hold substantial CAGR, due to rising usage of traditional approaches including spraying and wiping method.
Asia Pacific is anticipated to constitute a key market share
In terms of regions, the bio decontamination market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is expected to constitute a key share of the market during the forecast period, owing to rising production and export of pharmaceutical products. The market in North America is anticipated to expand at a rapid pace during the forecast period, due to stringent laws regarding the medical safety in the region.
Segments
The global bio decontamination market has been segmented on the basis of
Chemical Agents
- Nitrogen
- Peracetic Acid
- Hydrogen Peroxide
Products
- Services
- Equipment
- Consumables
Types
- Chamber Decontamination
- Room Decontamination
End-users
- Hospitals & Healthcare Facilities
- Clinics
- Biotechnology Research Organizations
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- JCE Biotechnology
- Fedegari Autoclavi SpA
- Steris PLC
- Ecolab
- TOMI Environmental Solutions, Inc
Competitive Landscape
Key players competing in the global bio decontamination market are JCE Biotechnology; Fedegari Autoclavi SpA; Steris PLC; Ecolab; and TOMI Environmental Solutions, Inc.
Key players in the market aggressively pursue strategic alliances, including partnerships and acquisitions, technical developments, and investments in order to strengthen their geographical footprint.
For instance, Chargepoint and Steris collaborated to offer integrated sterile transfer solutions in August 2020. For diverse applications in the production of biopharmaceuticals, the invention combined the AseptiSafe Bio Transfer Valve from the former with the VHP Bio-decontamination Systems from Steris.
Request For Customization
Enquiry Before Buying
Speak With Analyst
